Fresenius SE & Co. (OTCMKTS:FSNUY) Announces Quarterly Earnings Results

Fresenius SE & Co. (OTCMKTS:FSNUY) released its earnings results on Wednesday. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01), Zacks reports. Fresenius SE & Co. had a net margin of 5.71% and a return on equity of 10.31%.

Fresenius SE & Co. Price Performance

Shares of Fresenius SE & Co. stock traded up $0.30 during midday trading on Wednesday, hitting $11.91. 70,514 shares of the company traded hands, compared to its average volume of 142,768. The stock has a market cap of $26.83 billion, a price-to-earnings ratio of 18.91 and a beta of 0.68. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.00 and a current ratio of 1.32. The firm’s fifty day moving average price is $13.13 and its 200-day moving average price is $14.16. Fresenius SE & Co. has a 12 month low of $11.28 and a 12 month high of $33.93.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Citigroup reissued a “buy” rating on shares of Fresenius SE & Co. in a report on Tuesday, February 3rd. Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Fresenius SE & Co. currently has a consensus rating of “Buy”.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.